Tag: patient

  • My labs and CT were normal. Why am I still vomiting?

    My labs and CT were normal. Why am I still vomiting?

    Getting told “everything looks normal” while you’re still nauseated, still retching, and still can’t keep water down is one of the most frustrating experiences there is.

    Normal tests do not mean you’re faking it. They usually mean the ER team ruled out the fastest, scariest causes of vomiting (appendicitis, bowel blockage, bleeding, severe infection, etc.). The question becomes: what condition can cause real, repeated vomiting while leaving imaging and basic labs mostly normal?

    One answer that fits this pattern for many people is Cannabinoid Hyperemesis Syndrome (CHS): recurrent nausea/vomiting associated with frequent, long-term cannabis use, often with temporary relief from hot showers or baths.

    If you’re not sure what CHS is or how it’s diagnosed, start here: CHS Diagnosis & Misdiagnosis and CHS Research, Symptoms & Resources.


    First: if you can’t keep fluids down, treat it like an emergency

    Go to urgent care or the ER now if any of these are happening:

    • You can’t keep fluids down for hours and you’re still vomiting repeatedly
    • You’re getting weak, dizzy, confused, or faint
    • Very dark urine or barely peeing
    • Chest pain, severe abdominal pain, trouble breathing
    • Blood in vomit (or vomit that looks like coffee grounds)

    If you’re currently in that “I cannot stop vomiting” state, use this page as your checklist: What to Do If You Have Extreme Nausea or Vomiting After Smoking Weed.


    Why CHS can look “normal” on tests

    CHS is primarily a clinical diagnosis. That means it’s recognized by a pattern (symptoms + history) more than by one definitive scan or lab value. Emergency medicine guidance and clinical references emphasize that many tests can be unrevealing in CHS, especially early, which is part of why it gets missed.

    Good references on this clinical approach:

    What the ER is actually “clearing” with normal results

    When you have severe vomiting and abdominal pain, clinicians usually try to rule out problems that need immediate intervention. A “normal” workup often means:

    • No clear surgical emergency on imaging (like a bowel obstruction or appendicitis)
    • No obvious organ injury pattern on labs (though dehydration can still show up)
    • No red-flag findings that point to one single alternative cause

    That doesn’t make the vomiting any less real. It just means the most dangerous causes weren’t found in that moment.

    What can still be abnormal (and why it matters)

    Even when the CT is normal, vomiting can cause medically important changes:

    • Dehydration
    • Electrolyte problems (which can affect the heart and muscles)
    • Kidney stress/injury if dehydration is severe
    • Esophagus irritation/tears from repeated retching

    If your symptoms are escalating, don’t let “normal tests yesterday” stop you from going back.


    The pattern that makes CHS more likely (even with normal tests)

    CHS becomes much more plausible when the vomiting pattern matches and the cannabis pattern matches. Common clues include:

    • You use cannabis frequently (often daily or near-daily) and have for a long time
    • The nausea often hits in the morning or comes in cycles
    • You notice hot showers help, even temporarily
    • You’ve tried typical nausea meds and they didn’t do much
    • You’ve had repeat episodes and repeat ER visits without a clear diagnosis

    If you’re unsure whether you’re in the early stage vs the severe stage, this is the best “pattern recognition” page: What are the early warning signs of CHS?.

    For the shower/capsaicin clue (and why it’s temporary), see: Why hot showers and capsaicin relieve symptoms in CHS.


    “Why do I keep coming back to the ER for this?”

    This is a known CHS story arc: people can bounce between urgent care and the ER multiple times while tests keep coming back “fine.”

    There’s even research describing how delayed recognition leads to repeated ED visits and repeated imaging before CHS is identified:

    Separately, multiple studies show CHS-related ED encounters have increased over time in some settings (which likely reflects a mix of changing products, changing use patterns, and better recognition). For example:


    How to advocate for yourself (without sounding defensive)

    If you’re worried you’re being dismissed because tests are normal, focus on the pattern and the safety issues:

    • “I’m vomiting repeatedly and can’t keep fluids down.”
    • “This keeps happening in cycles.”
    • “I use cannabis most days (vape/flower/edibles), and I’m worried this could be CHS.”
    • “Hot showers help temporarily.”
    • “I’m concerned about dehydration and electrolytes.”

    If you’ve had multiple CTs already, it’s reasonable to mention it:

    • “I’ve had multiple CT scans for this. If you think imaging is needed again, can you tell me what new danger you’re looking for today?”

    That keeps the conversation medical and practical.


    What to do next if CHS is on the table

    1) Treat dehydration risk as urgent. If you can’t keep fluids down, you need medical care.

    2) Track the pattern for 7-14 days. It helps you and it helps a clinician:

    • time of day symptoms hit
    • what cannabis products you used (and how often)
    • whether hot showers help
    • whether symptoms come in episodes

    3) Take the “recurrence” part seriously. CHS is strongly associated with repeated cycles. If this is your second or third unexplained vomiting spell and cannabis use is frequent, don’t ignore that connection.

    4) If stopping cannabis feels impossible, that’s not a moral failure. It can be a sign of Cannabis Use Disorder, and help exists. Start with the overview: The Dangers of THC Poisoning.


    Disclaimer

    This is educational information, not medical advice. Persistent vomiting can become dangerous quickly. If you have severe symptoms or signs of dehydration, seek urgent or emergency care.

  • Can GLP-1 Medications Help with Cannabis Hyperemesis Syndrome?

    Can GLP-1 Medications Help with Cannabis Hyperemesis Syndrome?

    As researchers explore new treatment options for Cannabinoid Hyperemesis Syndrome (CHS), some people have wondered whether GLP-1 medications-the same drugs used for diabetes and weight management-might help with cannabis cessation or CHS symptoms. These medications, which include semaglutide (Ozempic, Wegovy) and liraglutide (Saxenda), have gained attention for their effects on appetite and substance use patterns.

    The short answer is: There is currently no research evidence to support using GLP-1 medications specifically for treating cannabis hyperemesis syndrome or helping CHS patients stop using cannabis. While these medications have shown promise in other contexts, no studies have examined their effectiveness for CHS patients.

    What Are GLP-1 Medications?

    GLP-1 (glucagon-like peptide-1) receptor agonists are medications originally developed for type 2 diabetes. They work by mimicking a hormone that helps regulate blood sugar and appetite. More recently, some formulations have been approved for weight management because they can reduce appetite and slow stomach emptying.

    These medications have also been studied for their potential effects on substance use behaviors, including alcohol use disorder and other addictions. This has led some to wonder whether they might help people with CHS stop using cannabis, which is the only true cure for the condition.

    The Research Gap

    A comprehensive review of the medical literature searched over 138 million academic papers to find studies examining whether GLP-1 medications are more effective than standard treatments for helping CHS patients stop using cannabis. The search found zero studies that directly addressed this question.

    This is a significant research gap. CHS is a serious condition that can cause life-threatening dehydration and electrolyte imbalances. Many people with CHS struggle to stop using cannabis, and standard antiemetic medications often don’t provide adequate relief during acute episodes. If GLP-1 medications could help with cannabis cessation in CHS patients, it would be valuable information-but we simply don’t have that data yet.

    What the Available Research Actually Shows

    While there are no studies on GLP-1 medications for CHS, there is one study that examined semaglutide in relation to cannabis use-but it looked at a completely different population and condition.

    The study examined patients with obesity and type 2 diabetes who were prescribed semaglutide or other medications. It found that people taking semaglutide had lower rates of being diagnosed with cannabis use disorder compared to people taking other medications for their conditions.

    Specifically, the study found:

    • About 44% lower risk of developing new cannabis use disorder in patients with obesity
    • About 38% lower risk of recurring cannabis use disorder in patients with obesity
    • Similar patterns in patients with type 2 diabetes

    Why This Doesn’t Apply to CHS

    While these findings might seem promising, they don’t tell us anything about whether GLP-1 medications could help CHS patients. Here’s why:

    Different Population

    The study didn’t include any patients with cannabis hyperemesis syndrome. Instead, it looked at people with obesity and diabetes who happened to have cannabis use disorder. CHS is a distinct condition that affects people differently than general cannabis use disorder.

    CHS patients often have a specific pattern of symptoms-severe cyclical vomiting, nausea, and abdominal pain that’s temporarily relieved by hot showers. They may have been using cannabis for years before developing CHS, and the condition creates a unique challenge for cessation because symptoms can worsen during withdrawal periods.

    Different Outcomes

    The study measured medical diagnoses of cannabis use disorder through electronic health records, not actual cannabis cessation or CHS symptom relief. It didn’t track:

    • Whether people actually stopped using cannabis
    • How much their cannabis use decreased
    • Whether CHS symptoms improved
    • Emergency department visits for CHS
    • Quality of life measures

    These are the outcomes that matter for CHS patients, but the study didn’t measure them.

    Different Context

    The study was observational and retrospective, meaning it looked back at existing medical records rather than actively testing whether semaglutide helps people stop using cannabis. This type of study can show associations but cannot prove that semaglutide caused the lower rates of cannabis use disorder diagnoses.

    There could be many reasons why people taking semaglutide had fewer cannabis use disorder diagnoses that have nothing to do with the medication itself. For example, people who are actively managing their diabetes or obesity with medication might be more engaged in their healthcare overall, or they might have different motivations or support systems.

    The Need for Dedicated Research

    The research review concluded that “the comparative effectiveness of GLP intervention versus standard treatment for cannabis cessation in CHS patients remains unknown and requires dedicated research in this specific clinical population.”

    This means we need studies that:

    • Specifically recruit patients with diagnosed CHS
    • Compare GLP-1 medications to standard CHS treatment protocols
    • Measure actual cannabis cessation outcomes (not just diagnoses)
    • Track CHS symptom resolution
    • Monitor safety and side effects in CHS patients
    • Follow patients long enough to see if cessation is sustained

    Until such research is conducted, we cannot know whether GLP-1 medications might be helpful for CHS patients trying to stop using cannabis.

    Why This Matters

    CHS is a challenging condition to treat. Standard antiemetic medications like ondansetron and prochlorperazine are often ineffective, which is why researchers have been exploring new treatment options like aprepitant. The fact that there’s no research on GLP-1 medications for CHS represents a missed opportunity to potentially help people who are struggling.

    If GLP-1 medications could help CHS patients stop using cannabis-which is the only true cure for the condition-that would be valuable information. But we need proper research to answer that question, not assumptions based on studies in completely different populations.

    What This Means for People with CHS

    If you’re dealing with CHS and wondering whether a GLP-1 medication might help you stop using cannabis, here’s what you should know:

    There’s No Evidence Yet

    Currently, there’s no research to support using GLP-1 medications specifically for CHS or cannabis cessation in CHS patients. This doesn’t mean they definitely won’t work-it just means we don’t have the data to know either way.

    Standard Approaches Remain the Foundation

    The only proven cure for CHS is complete and permanent cessation of cannabis use. While this can be challenging, especially during withdrawal periods when symptoms may temporarily worsen, it’s the only approach with clear evidence of effectiveness.

    Treatment During Episodes

    For managing acute CHS episodes, emerging treatments like aprepitant may be more effective than traditional antiemetics. Supportive care including IV fluids for hydration is crucial, as severe dehydration can be life-threatening.

    Talk to Your Doctor

    If you’re interested in exploring GLP-1 medications, discuss this with your healthcare provider. They can help you understand:

    • Whether a GLP-1 medication might be appropriate for other health conditions you have
    • The potential risks and benefits
    • That there’s no evidence specifically for CHS
    • Other options for supporting cannabis cessation

    Your doctor can also help you access resources for stopping cannabis use, such as addiction medicine specialists or outpatient programs.

    The Research Landscape Moving Forward

    The fact that semaglutide showed associations with lower cannabis use disorder rates in other populations has generated interest in whether these medications might help with substance use more broadly. However, translating findings from one population to another requires careful research.

    For CHS specifically, we need studies designed to answer the right questions:

    • Can GLP-1 medications help CHS patients achieve and maintain cannabis cessation?
    • Do they provide any benefit beyond standard cessation support?
    • Are they safe for CHS patients, who may have specific health considerations?
    • How do they compare to other emerging treatments like aprepitant for managing acute episodes?

    These are important questions that deserve dedicated research. Until that research is conducted, we’re operating without evidence-which means we can’t confidently recommend GLP-1 medications for CHS, even if they might theoretically have benefits.

    Conclusion

    GLP-1 medications have shown promise in various contexts, from diabetes management to weight loss to potentially reducing substance use in some populations. However, when it comes to cannabis hyperemesis syndrome specifically, we’re facing a significant research gap.

    There is currently no evidence to support using GLP-1 medications for treating CHS or helping CHS patients stop using cannabis. The single study that examined these medications in relation to cannabis use looked at completely different populations and outcomes, so its findings don’t apply to CHS.

    This doesn’t mean GLP-1 medications definitely won’t help-it just means we need proper research to find out. Until that research is conducted, the only proven cure for CHS remains complete and permanent cessation of cannabis use, supported by appropriate medical care during acute episodes.

    If you’re struggling with CHS, focus on proven approaches: complete cessation, medical support during episodes, and emerging treatments like aprepitant that have shown promise specifically for CHS. As research continues to evolve, we may learn more about whether GLP-1 medications have a role to play-but for now, we’re working with the evidence we have, not the evidence we wish we had.

  • Is There a Cure for CHS?

    Is There a Cure for CHS?

    Cannabinoid Hyperemesis Syndrome (CHS) is a challenging condition that affects people who use cannabis regularly. When people experience the severe nausea, vomiting, and abdominal pain that characterize CHS, they often wonder: is there a cure? What will cure THC poisoning? Can anything make this stop?

    The short answer is both straightforward and complex: The only definitive cure for CHS is complete and permanent cessation of cannabis use. However, there are treatments that can help manage symptoms during episodes, and emerging research is exploring new medications that may provide relief. Understanding the difference between treatment and cure is crucial for anyone dealing with this condition.

    Understanding What “Cure” Means for CHS

    When people ask what will cure THC poisoning or CHS, it’s important to understand what that means. Unlike some medical conditions where a medication can eliminate the problem, CHS is directly caused by chronic cannabis use. The cannabinoids in cannabis-particularly THC-accumulate in the body over time and disrupt the normal functioning of the endocannabinoid system, which plays a role in regulating nausea, vomiting, and gastrointestinal function.

    Think of it like this: if you have an allergic reaction to something you’re eating, the reaction will continue as long as you keep eating that food. Similarly, CHS symptoms will continue and worsen as long as you continue using cannabis. The body needs time to clear the accumulated cannabinoids and for the endocannabinoid system to return to normal function. This is why there’s no medication that can cure CHS while cannabis use continues-the underlying cause must be addressed first.

    The Only True Cure: Cannabis Cessation

    Complete abstinence from all forms of cannabis is the only way to permanently resolve CHS. This includes:

    • Marijuana (flower, edibles, concentrates)
    • THC-A products (which convert to THC when heated)
    • Delta-8, Delta-10, and other “legal” THC variants
    • Full-spectrum CBD products that contain THC
    • Any other cannabis-derived products containing cannabinoids

    When someone stops using cannabis completely, their symptoms typically resolve within days to weeks, though some people may experience lingering effects for longer periods. The key is permanent cessation-returning to cannabis use will cause CHS symptoms to return, often more severely than before.

    Treatment Options During CHS Episodes

    While there’s no medication that “cures” CHS while continuing cannabis use, several treatments can help manage symptoms during acute episodes:

    Standard Antiemetic Medications

    Traditional anti-nausea medications are often tried first, though they have limited effectiveness in CHS. Standard first-line antiemetics such as ondansetron and prochlorperazine are often ineffective in treating cannabinoid hyperemesis syndrome, which is one reason why CHS can be so difficult to manage:

    • Ondansetron (Zofran): A 5-HT3 receptor antagonist commonly used for nausea, but often ineffective in CHS
    • Prochlorperazine: Another standard antiemetic that frequently fails to provide relief in CHS cases
    • Promethazine (Phenergan): An antihistamine with antiemetic properties
    • Metoclopramide (Reglan): A prokinetic agent that can help with gastric emptying
    • Haloperidol: An antipsychotic that has shown some effectiveness in CHS cases

    Unfortunately, many people with CHS find that these standard medications don’t provide adequate relief, which is why researchers are exploring new treatment options like aprepitant that target different pathways in the body’s nausea and vomiting response.

    Hot Showers and Capsaicin Cream

    One of the most distinctive features of CHS is that hot showers or baths provide temporary relief from symptoms. This is thought to work through activation of TRPV1 receptors in the skin, which may help reset the body’s nausea and vomiting pathways. Some people also find relief from applying capsaicin cream (the active ingredient in chili peppers) to their abdomen, which works through similar mechanisms.

    While these methods provide temporary relief, they’re not cures-they’re symptom management techniques that can help people get through acute episodes.

    Emerging Treatment: Aprepitant

    Recent research has explored the use of aprepitant (brand name Emend) as a potential treatment for CHS. Aprepitant is a neurokinin-1 (NK-1) receptor antagonist that’s currently approved for preventing chemotherapy-induced and postoperative nausea and vomiting.

    study published in Cureus examined the emerging role of aprepitant in treating CHS. The research suggests that aprepitant may be more effective than traditional antiemetics for CHS because it targets different pathways in the brain’s vomiting center.

    How Aprepitant Works

    Aprepitant works by blocking neurokinin-1 receptors in the brain. These receptors are involved in the body’s nausea and vomiting response. By blocking these receptors, aprepitant can interrupt the cycle of severe nausea and vomiting that characterizes CHS episodes.

    The medication is typically given in a hospital setting, often as part of a treatment protocol that includes:

    • Intravenous aprepitant (or oral formulation)
    • Supportive care including IV fluids for hydration
    • Other medications as needed

    What the Research Shows

    Aprepitant has been identified as having strong potential in treating protracted vomiting episodes in individuals with CHS. This is particularly significant because standard first-line antiemetics such as ondansetron (Zofran) and prochlorperazine are often ineffective in treating cannabinoid hyperemesis syndrome.

    Case studies and small clinical reports have shown promising results with aprepitant in CHS patients who haven’t responded to standard treatments. The fact that aprepitant targets different pathways (NK-1 receptors) than traditional antiemetics may explain why it appears to be more effective for CHS, which doesn’t respond well to medications that work for other types of nausea and vomiting.

    However, it’s important to note that:

    • Aprepitant is not a cure-it’s a treatment for acute episodes
    • Research is still emerging, and larger studies are needed
    • The medication must be prescribed by a healthcare provider
    • It’s typically used in emergency or hospital settings
    • Cannabis cessation is still required for long-term resolution

    Aprepitant may help break the cycle of severe vomiting during an acute CHS episode, which can be life-threatening due to dehydration and electrolyte imbalances. This can buy time and provide relief while the person works toward complete cannabis cessation.

    The Broader Context of NK-1 Receptor Antagonists

    Aprepitant belongs to a class of medications called NK-1 receptor antagonists. Research has explored the potential of these medications for various conditions beyond their current approved uses. While plans to develop aprepitant specifically as an antidepressant were withdrawn, other NK-1 receptor antagonists have shown promising results in clinical trials for depression and other conditions. This suggests that the NK-1 receptor pathway may play important roles in multiple systems in the body, which could explain why aprepitant appears effective for CHS when other antiemetics fail.

    The broader research into NK-1 receptor antagonists highlights that these medications may have therapeutic potential beyond their current uses, though much of the data remains proprietary and more research is needed to fully understand their potential applications.

    Supportive Care and Hospital Treatment

    During severe CHS episodes, hospitalization is often necessary. Treatment in the hospital typically includes:

    • IV Fluids: To treat dehydration and restore electrolyte balance
    • Pain Management: For severe abdominal pain
    • Antiemetic Medications: Including aprepitant or other options
    • Monitoring: For complications like kidney injury or electrolyte abnormalities
    • Psychiatric Support: To help with cannabis cessation and withdrawal

    What to Ask for at the Hospital

    If you’re experiencing severe CHS symptoms and need to go to the hospital, it’s important to advocate for yourself. Not all healthcare providers are familiar with CHS or the most effective treatment options. Here’s what you should know:

    Be Honest About Your Cannabis Use

    The most important thing you can do is be completely honest with your healthcare providers about your cannabis use. This information is crucial for proper diagnosis and treatment. Some people feel embarrassed or worried about judgment, but healthcare providers need this information to help you effectively.

    Ask About CHS-Specific Treatments

    If standard antiemetic medications aren’t working, you can ask your doctor about:

    • Aprepitant (Emend): This is a newer treatment option that may be more effective for CHS than traditional antiemetics. Research suggests it may work better because it targets different pathways in the brain’s vomiting center. You can ask: “I’ve heard that aprepitant might be more effective for CHS than standard antiemetics. Is that something we could try?”
    • Haloperidol: Some studies have shown this antipsychotic medication can be effective for CHS when other treatments fail. It’s not a first-line treatment, but it may be worth discussing if other options haven’t worked.

    Request Proper Hydration and Monitoring

    Severe CHS episodes can cause life-threatening dehydration and electrolyte imbalances. Make sure your healthcare team is:

    • Providing adequate IV fluids
    • Monitoring your electrolyte levels (sodium, potassium, etc.)
    • Checking kidney function
    • Monitoring for complications

    Ask About Pain Management

    The abdominal pain associated with CHS can be severe. Don’t hesitate to ask for appropriate pain management if you’re in significant discomfort.

    Request Information About Cannabis Cessation Support

    While you’re in the hospital, ask about resources for stopping cannabis use. Many hospitals have addiction medicine specialists or can refer you to outpatient programs that can help with cessation and withdrawal management.

    What If Your Doctor Doesn’t Know About CHS?

    Unfortunately, not all healthcare providers are familiar with CHS. If your doctor seems unfamiliar with the condition, you can:

    • Politely mention that you believe you may have Cannabinoid Hyperemesis Syndrome
    • Explain that you’ve found that hot showers provide temporary relief (this is a distinctive feature of CHS)
    • Ask if they could consult with a gastroenterologist or emergency medicine specialist who may be more familiar with the condition
    • Request that they look up current treatment guidelines for CHS

    Remember: You have the right to advocate for your care. If you’re not getting relief from standard treatments, it’s appropriate to ask about alternative options like aprepitant, especially if you’re experiencing severe, persistent symptoms.

    The Reality of Treatment vs. Cure

    It’s important to be clear about what treatments can and cannot do:

    What treatments CAN do:

    • Provide relief during acute episodes
    • Prevent life-threatening complications like severe dehydration
    • Help manage symptoms while working toward cessation
    • Support the body’s recovery process

    What treatments CANNOT do:

    • Cure CHS while continuing cannabis use
    • Prevent future episodes if cannabis use resumes
    • Replace the need for complete cessation
    • Work permanently without addressing the root cause

    Why There’s No “Magic Pill”

    Some people hope for a medication that will cure THC poisoning or allow them to continue using cannabis without experiencing CHS symptoms. Unfortunately, this isn’t how CHS works. The condition develops because the body’s endocannabinoid system becomes overwhelmed and dysregulated by chronic cannabinoid exposure. No medication can fix this underlying problem while cannabinoids continue to be introduced into the system.

    The endocannabinoid system needs time to reset, and this can only happen when cannabis use stops completely. This is why even the most promising treatments like aprepitant are used to manage acute episodes, not as long-term solutions that allow continued cannabis use. There is no medication that can cure CHS while cannabis use continues-the only true cure is complete cessation.

    The Path Forward

    If you’re suffering from CHS, here’s what you need to know:

    1. Complete cessation is the only cure-but it works. Many people see significant improvement within days of stopping cannabis use.
    2. Treatment options exist for managing acute episodes, including emerging treatments like aprepitant that may be more effective than traditional antiemetics.
    3. Medical support is crucial-don’t try to manage severe CHS episodes alone. Dehydration and electrolyte imbalances can be life-threatening.
    4. Recovery is possible-with complete cessation, most people fully recover from CHS, though the timeline varies from person to person.
    5. Prevention is key-once you’ve recovered, returning to cannabis use will cause CHS to return. The only way to prevent future episodes is permanent abstinence.

    Talking to Your Doctor

    If you’re experiencing CHS symptoms and wondering what will cure THC poisoning or CHS, it’s important to talk to a healthcare provider who understands the condition. Be honest about your cannabis use-this information is crucial for proper diagnosis and treatment. Your doctor can:

    • Confirm the diagnosis
    • Provide appropriate treatment during acute episodes
    • Discuss options like aprepitant if standard treatments aren’t working
    • Support you in cannabis cessation
    • Monitor your recovery

    Some emergency departments and hospitals are becoming more familiar with CHS and newer treatment options. If you’re in a severe episode, don’t hesitate to seek emergency care. When you go to the hospital, be prepared to advocate for yourself and ask about treatment options that may be more effective for CHS specifically.

    What will cure THC poisoning?

    The question “Is there a cure for CHS?” or “What will cure THC poisoning?” has a clear answer: Yes, but it requires complete and permanent cessation of cannabis use. While this may seem daunting, it’s important to remember that:

    • The cure is within your control
    • Treatment options exist to help you through acute episodes
    • Recovery is possible and often happens relatively quickly
    • Medical support is available to help you through the process

    Emerging treatments like aprepitant may offer better symptom management during acute episodes, which can be crucial for people experiencing severe, life-threatening symptoms. However, these treatments are tools to help you get through the crisis, not replacements for the fundamental solution of cannabis cessation.

    If you’re struggling with CHS, know that you’re not alone, and that recovery is possible. The path forward involves stopping cannabis use completely and working with healthcare providers who can support you through both the acute episodes and the long-term recovery process. When you need hospital care, don’t hesitate to ask about treatment options that may be more effective for CHS, including newer medications like aprepitant if standard treatments aren’t providing relief.

    Sources and Further Reading

    Let us know your thoughts.

  • When CHS Becomes Life-Threatening

    When CHS Becomes Life-Threatening

    Cannabinoid Hyperemesis Syndrome (CHS) is typically described as a debilitating but non-fatal condition characterized by recurrent nausea, uncontrollable vomiting, and abdominal pain in people with long-term heavy cannabis use. However, there are documented cases – both in medical literature and shared in patient communities – where complications of CHS have contributed to severe health outcomes, including death.

    Have People Died From CHS?

    Several individuals in online CHS communities have shared heartbreaking accounts of loved ones who died after prolonged or severe CHS episodes. In one widely discussed case, a parent reported that her 38-year-old son’s death was attributed on his death certificate to cardiac arrest related to CHS, with dehydration and electrolyte imbalance cited as likely contributing factors. Members described long periods of vomiting, dehydration, and strain on the body preceding his death. Reddit

    Other community posts recount similarly tragic experiences, including reports of cardiac arrest or fatal complications occurring in people struggling with ongoing CHS symptoms. While these individual reports cannot be independently verified here, they reflect the lived fears and outcomes shared by some community members. Reddit

    It’s important to note that these are anecdotal accounts, not clinical case reports, but they highlight why many patients and caregivers take the risk of severe complications seriously.


    What Medical Research Says About Risk and Fatality

    In the clinical literature, fatal outcomes directly attributable to CHS are rare but documented. Case reports published in medical journals describe individuals with cyclical vomiting who experienced fatal complications such as dehydration and electrolyte imbalances. These reports emphasize that the cause of death is not cannabis itself, but severe, protracted vomiting and its effects on the body. PubMed

    Other reviews summarizing outcomes from CHS note that complications of persistent vomiting – including dehydration, electrolyte abnormalities, kidney injury, and heart rhythm disturbances – can be serious and potentially life-threatening if not treated promptly. National Geographic


    Why These Outcomes Occur

    If someone with CHS experiences prolonged vomiting without adequate fluid and electrolyte replacement, the body can enter a dangerous state of:

    • Severe dehydration, reducing blood volume
    • Electrolyte imbalances, affecting heart and kidney function
    • Metabolic disturbances, complicating normal cellular processes

    These physiological stresses – particularly without medical intervention – can result in complications such as cardiac arrest or organ failure in rare cases. Welly


    What This Means for Patients and Caregivers

    A few takeaways from the clinical evidence and community reports:

    • Deaths directly caused by CHS are rare, but they do occur and are generally linked to secondary complications, not the cannabis itself. PubMed
    • Prompt medical care for dehydration and electrolyte imbalance is essential.
    • Cessation of cannabis use is the only known way to prevent recurrence of CHS symptoms. JAMA Network
    • Community-shared experiences, while not clinical evidence, underscore the lived reality of risk that many people with CHS describe.

    A Note on Reporting and Awareness

    Because CHS is often underdiagnosed and can mimic other gastrointestinal disorders, many severe cases may go unrecognized or be attributed to other causes. As recognition of CHS grows among clinicians and researchers, more accurate tracking of outcomes – including rare fatal complications – will help inform both patients and providers.

    For a thorough clinical overview of CHS symptoms, diagnosis, and management, see our main Cannabinoid Hyperemesis Syndrome (CHS) page.


    See the research below, courtesy of Elicit